Literature DB >> 32374878

Mutational dynamics and immune evasion in diffuse large B-cell lymphoma explored in a relapse-enriched patient series.

Jillian F Wise1,2,3,4,5,6, Sigve Nakken2,7,8,9, Chloé B Steen1,10, Daniel Vodák2,7,8, Gunhild Trøen11, Bjarne Johannessen8,12, Ole Christian Lingjærde10, Vera Hilden1,3, Yngvild Nuvin Blaker1,3,8, Baoyan Bai1,3, Lars Birger Aasheim2,7, Annika Pasanen13,14, Susanne Lorenz2,7,15, Anita Sveen8,12, Ragnhild A Lothe2,8,12, Ola Myklebost2,7,16, Sirpa Leppä13,14, Leonardo A Meza-Zepeda2,7,15, Klaus Beiske8,11, Michael S Lawrence4,5,6, Eivind Hovig2,7,10, June Helen Myklebust1,3, Erlend B Smeland1,2,3, Harald Holte2,3,17.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32374878      PMCID: PMC7218413          DOI: 10.1182/bloodadvances.2019001325

Source DB:  PubMed          Journal:  Blood Adv        ISSN: 2473-9529


× No keyword cloud information.
  43 in total

1.  FACETS: allele-specific copy number and clonal heterogeneity analysis tool for high-throughput DNA sequencing.

Authors:  Ronglai Shen; Venkatraman E Seshan
Journal:  Nucleic Acids Res       Date:  2016-06-07       Impact factor: 16.971

2.  Integrative analysis reveals an outcome-associated and targetable pattern of p53 and cell cycle deregulation in diffuse large B cell lymphoma.

Authors:  Stefano Monti; Bjoern Chapuy; Kunihiko Takeyama; Scott J Rodig; Yansheng Hao; Kelly T Yeda; Haig Inguilizian; Craig Mermel; Treeve Currie; Ahmet Dogan; Jeffery L Kutok; Rameen Beroukhim; Donna Neuberg; Thomas M Habermann; Gad Getz; Andrew L Kung; Todd R Golub; Margaret A Shipp
Journal:  Cancer Cell       Date:  2012-09-11       Impact factor: 31.743

3.  Long-Duration Complete Remissions of Diffuse Large B Cell Lymphoma after Anti-CD19 Chimeric Antigen Receptor T Cell Therapy.

Authors:  James N Kochenderfer; Robert P T Somerville; Tangying Lu; James C Yang; Richard M Sherry; Steven A Feldman; Lori McIntyre; Adrian Bot; John Rossi; Norris Lam; Steven A Rosenberg
Journal:  Mol Ther       Date:  2017-07-13       Impact factor: 11.454

4.  Dynamic Risk Profiling Using Serial Tumor Biomarkers for Personalized Outcome Prediction.

Authors:  David M Kurtz; Mohammad S Esfahani; Florian Scherer; Joanne Soo; Michael C Jin; Chih Long Liu; Aaron M Newman; Ulrich Dührsen; Andreas Hüttmann; Olivier Casasnovas; Jason R Westin; Matthais Ritgen; Sebastian Böttcher; Anton W Langerak; Mark Roschewski; Wyndham H Wilson; Gianluca Gaidano; Davide Rossi; Jasmin Bahlo; Michael Hallek; Robert Tibshirani; Maximilian Diehn; Ash A Alizadeh
Journal:  Cell       Date:  2019-07-04       Impact factor: 41.582

5.  Outcomes in patients with aggressive B-cell non-Hodgkin lymphoma after intensive frontline treatment failure.

Authors:  Emily C Ayers; Shaoying Li; L Jeffrey Medeiros; David A Bond; Kami J Maddocks; Pallawi Torka; Angel Mier Hicks; Madeira Curry; Nina D Wagner-Johnston; Reem Karmali; Amir Behdad; Bita Fakhri; Brad S Kahl; Michael C Churnetski; Jonathon B Cohen; Nishitha M Reddy; Dipenkumar Modi; Radhakrishnan Ramchandren; Christina Howlett; Lori A Leslie; Samuel Cytryn; Catherine S Diefenbach; Rawan Faramand; Julio C Chavez; Adam J Olszewski; Yang Liu; Stefan K Barta; Dhruvika Mukhija; Brian T Hill; Helen Ma; Jennifer E Amengual; Sunita Nathan; Sarit E Assouline; Victor M Orellana-Noia; Craig A Portell; Ashwin Chandar; Kevin A David; Anshu Giri; Brian T Hess; Daniel J Landsburg
Journal:  Cancer       Date:  2019-09-30       Impact factor: 6.860

6.  Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma.

Authors:  Anupama Reddy; Jenny Zhang; Nicholas S Davis; Andrea B Moffitt; Cassandra L Love; Alexander Waldrop; Sirpa Leppa; Annika Pasanen; Leo Meriranta; Marja-Liisa Karjalainen-Lindsberg; Peter Nørgaard; Mette Pedersen; Anne O Gang; Estrid Høgdall; Tayla B Heavican; Waseem Lone; Javeed Iqbal; Qiu Qin; Guojie Li; So Young Kim; Jane Healy; Kristy L Richards; Yuri Fedoriw; Leon Bernal-Mizrachi; Jean L Koff; Ashley D Staton; Christopher R Flowers; Ora Paltiel; Neta Goldschmidt; Maria Calaminici; Andrew Clear; John Gribben; Evelyn Nguyen; Magdalena B Czader; Sarah L Ondrejka; Angela Collie; Eric D Hsi; Eric Tse; Rex K H Au-Yeung; Yok-Lam Kwong; Gopesh Srivastava; William W L Choi; Andrew M Evens; Monika Pilichowska; Manju Sengar; Nishitha Reddy; Shaoying Li; Amy Chadburn; Leo I Gordon; Elaine S Jaffe; Shawn Levy; Rachel Rempel; Tiffany Tzeng; Lanie E Happ; Tushar Dave; Deepthi Rajagopalan; Jyotishka Datta; David B Dunson; Sandeep S Dave
Journal:  Cell       Date:  2017-10-05       Impact factor: 41.582

7.  Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma.

Authors:  Roland Schmitz; George W Wright; Da Wei Huang; Calvin A Johnson; James D Phelan; James Q Wang; Sandrine Roulland; Monica Kasbekar; Ryan M Young; Arthur L Shaffer; Daniel J Hodson; Wenming Xiao; Xin Yu; Yandan Yang; Hong Zhao; Weihong Xu; Xuelu Liu; Bin Zhou; Wei Du; Wing C Chan; Elaine S Jaffe; Randy D Gascoyne; Joseph M Connors; Elias Campo; Armando Lopez-Guillermo; Andreas Rosenwald; German Ott; Jan Delabie; Lisa M Rimsza; Kevin Tay Kuang Wei; Andrew D Zelenetz; John P Leonard; Nancy L Bartlett; Bao Tran; Jyoti Shetty; Yongmei Zhao; Dan R Soppet; Stefania Pittaluga; Wyndham H Wilson; Louis M Staudt
Journal:  N Engl J Med       Date:  2018-04-12       Impact factor: 91.245

8.  Analysis of the coding genome of diffuse large B-cell lymphoma.

Authors:  Laura Pasqualucci; Vladimir Trifonov; Giulia Fabbri; Jing Ma; Davide Rossi; Annalisa Chiarenza; Victoria A Wells; Adina Grunn; Monica Messina; Oliver Elliot; Joseph Chan; Govind Bhagat; Amy Chadburn; Gianluca Gaidano; Charles G Mullighan; Raul Rabadan; Riccardo Dalla-Favera
Journal:  Nat Genet       Date:  2011-07-31       Impact factor: 38.330

9.  Mutational Evolution in Relapsed Diffuse Large B-Cell Lymphoma.

Authors:  Marcel Nijland; Annika Seitz; Martijn Terpstra; Gustaaf W van Imhoff; Philip M Kluin; Tom van Meerten; Çiğdem Atayar; Léon C van Kempen; Arjan Diepstra; Klaas Kok; Anke van den Berg
Journal:  Cancers (Basel)       Date:  2018-11-20       Impact factor: 6.639

10.  Mutational heterogeneity in cancer and the search for new cancer-associated genes.

Authors:  Michael S Lawrence; Petar Stojanov; Paz Polak; Gregory V Kryukov; Kristian Cibulskis; Andrey Sivachenko; Scott L Carter; Chip Stewart; Craig H Mermel; Steven A Roberts; Adam Kiezun; Peter S Hammerman; Aaron McKenna; Yotam Drier; Lihua Zou; Alex H Ramos; Trevor J Pugh; Nicolas Stransky; Elena Helman; Jaegil Kim; Carrie Sougnez; Lauren Ambrogio; Elizabeth Nickerson; Erica Shefler; Maria L Cortés; Daniel Auclair; Gordon Saksena; Douglas Voet; Michael Noble; Daniel DiCara; Pei Lin; Lee Lichtenstein; David I Heiman; Timothy Fennell; Marcin Imielinski; Bryan Hernandez; Eran Hodis; Sylvan Baca; Austin M Dulak; Jens Lohr; Dan-Avi Landau; Catherine J Wu; Jorge Melendez-Zajgla; Alfredo Hidalgo-Miranda; Amnon Koren; Steven A McCarroll; Jaume Mora; Brian Crompton; Robert Onofrio; Melissa Parkin; Wendy Winckler; Kristin Ardlie; Stacey B Gabriel; Charles W M Roberts; Jaclyn A Biegel; Kimberly Stegmaier; Adam J Bass; Levi A Garraway; Matthew Meyerson; Todd R Golub; Dmitry A Gordenin; Shamil Sunyaev; Eric S Lander; Gad Getz
Journal:  Nature       Date:  2013-06-16       Impact factor: 49.962

View more
  3 in total

Review 1.  Treatment resistance in diffuse large B-cell lymphoma.

Authors:  Michael Y He; Robert Kridel
Journal:  Leukemia       Date:  2021-05-20       Impact factor: 11.528

2.  The mutational profile of immune surveillance genes in diagnostic and refractory/relapsed DLBCLs.

Authors:  Marijana Nesic; Mads Sønderkær; Rasmus Froberg Brøndum; Tarec Christoffer El-Galaly; Inge Søkilde Pedersen; Martin Bøgsted; Karen Dybkær
Journal:  BMC Cancer       Date:  2021-07-18       Impact factor: 4.430

3.  Genomic complexity is associated with epigenetic regulator mutations and poor prognosis in diffuse large B-cell lymphoma.

Authors:  Hua You; Zijun Y Xu-Monette; Li Wei; Harry Nunns; Máté L Nagy; Govind Bhagat; Xiaosheng Fang; Feng Zhu; Carlo Visco; Alexandar Tzankov; Karen Dybkaer; April Chiu; Wayne Tam; Youli Zu; Eric D Hsi; Fredrick B Hagemeister; Jooryung Huh; Maurilio Ponzoni; Andrés J M Ferreri; Michael B Møller; Benjamin M Parsons; J Han Van Krieken; Miguel A Piris; Jane N Winter; Yong Li; Qingyan Au; Bing Xu; Maher Albitar; Ken H Young
Journal:  Oncoimmunology       Date:  2021-07-20       Impact factor: 8.110

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.